The CanSino Pharmaceutical recommended this Sunday, August 8, 2021 to apply a reinforcement from his vaccine against covid-19 six months after receiving the first dose, after a study made by the company, which has already been delivered to the sanitary Authority Mexican.
“The biopharmaceutical company CanSino Biologics (CanSino BIO) reports that it has obtained new, precise and conclusive results that the levels of neutralizing antibodies in its anticovid vaccine remain high – by almost 70% – in people, six months after being vaccinated with this unit dose ”, indicated the pharmacist in a statement.
It also pointed out that a second dose of the vaccine achieves that the levels of neutralizing antibodies I know multiply for eight. “A second application of the CanSino vaccine does provide greater protection to those who have received it, and it is safe,” said the document.
He indicated that the studies found that for those who received two injections of vaccines of inactivated virus, a third application of the biological as a reinforcement, it has generated levels of antibodies “several times higher than the products by the application as booster of other doses of inactivated virus vaccines”.
He reiterated that his vaccine It is “highly safe that provides lasting protection – more than six months -, avoids hospitalization and death in 90% of the people to whom it is applied.”
He recalled that it continues with phase III of the clinical trials of its biological in Mexico, in which 15,000 volunteers from Mexico, and as soon as final results are obtained, modifications related to the number of necessary doses of the vaccine will be made.
Up to now, Mexico has received nearly 13 million doses of CanSino of a total of 35 million acquired and with this drug, the government vaccinated all public and private educational personnel in the 32 states of the country.
Mexico has supplied a total of 71.6 million vaccines of various drugs in a country of 126 million people, although only 27.13 have a complete scheme.
In addition to CanSino the country has committed 34.4 million dose of the american Pfizer, 79.4 million of the Anglo-Swedish AstraZeneca, 24 million from the Russian Sputnik V, 20 million from the china Sinovac, 12 million from also Chinese Sinopharm and 51.4 million of the Covax platform from WHO.
–
